Understanding and Communicating the Strengths and Weaknesses of RWE for Market Access

Understanding and Communicating the Strengths and Weaknesses of RWE for Market Access


Real-world evidence (RWE) provides stakeholders with a more holistic view of a product’s potential and informs market access decision-making.

But RWE can be based on a variety of real-world data sources, each with its own strengths and weaknesses.

So, which RWE will resonate with HTAs and payers?

Why is it critical to be transparent?

How can RWE be nuanced to communicate with all stakeholders?

Companies

Kaiser Permanente, IQVIA, Dreyer Strategies


Subject synopsis
Research methodology and objectives
Key insights summary
Issues and insights
RWE to overcome limited evidence
Issue summary
Questions
Key insights
Supporting quotes
Strengths of RWE
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Weaknesses of RWE
Issue summary
Questions
Key insights
Supporting quotes
RWE that is acceptable to HTA agencies
Issue summary
Questions
Key insights
Supporting quotes

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings